Arcus Biosciences Inc (RCUS)
$18.19 -2.26% Close Oct 30, 2026 Live
Arcus Biosciences stock today
Arcus Biosciences closed at $18.19 on October 30, 2026, down 2.26% on the day. Over the past year it returned -9.9% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $2.29 billion.
$20.00$25.00$30.00
NovJan 2026MarMayJulSep
| Period | RCUS | S&P 500 (SPY) |
|---|---|---|
| 1 month | -29.6% | -0.9% |
| 3 months | -35.6% | +2.1% |
| Year to date | -23.7% | +11.7% |
| 1 year | -9.9% | +12.4% |
| 3 years | +21.7% | +88.5% |
| 5 years | -45.6% | +76.0% |
Key statistics
- Market value
- $2.29B
- Price / sales
- 19.6
- 52-week range
- $17.76 to $31.57
- Next report
- Nov 4, 2026
About Arcus Biosciences
Biopharmaceutical company developing immuno-oncology and cell therapy treatments.
Sector: Health Care
More on Arcus Biosciences
- Financials: revenue, earnings and segmentsRevenue -4% in the year to Dec 2025
- Returns: what $1,000 became$1,000 five years ago is $543.96 today
No forecast, no recommendation. This page describes Arcus Biosciences Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.